Skip to main content
Medistim logo

Medistim — Investor Relations & Filings

Ticker · MEDI ISIN · NO0010159684 LEI · 5967007LIEEXZXJOX483 OL Manufacturing
Open in API
Filings indexed 783 across all filing types
Latest filing 2014-07-09 Major Shareholding Noti…
Country NO Norway
Listing OL MEDI

About Medistim

https://medistim.com/

Medistim is a medical technology company specializing in intraoperative quality assessment solutions. A pioneer and market leader in Transit Time Flow Measurement (TTFM), the company develops and manufactures advanced medical devices for use during surgical procedures. Its flagship MiraQ™ system uniquely combines TTFM with high-frequency ultrasound imaging, providing surgeons with real-time data to verify graft function and blood flow. This technology is applied in cardiac, vascular, and transplant surgery to enhance procedural quality control and improve patient outcomes.

Recent filings

Filing Released Lang Actions
Changes in ownership structure in Medistims second largest shareholder Chr Salvesen & Chr Thamshavn's Communications Aktieselskab
Major Shareholding Notification Classification · 99% confidence The document explicitly details a change in ownership structure concerning a significant shareholder (Chr Salvesen & Chr Thamshavn's Communications Aktieselskab) transferring 1,862,500 shares in Medistim ASA to an affiliated entity (Thams Invest AS) through a reorganization involving a demerger and merger. This type of announcement, concerning changes in significant share ownership or control blocks, aligns best with the Major Shareholding Notification (MRQ) definition, which covers notifications of changes in significant share ownership levels crossing thresholds. Although it describes a transaction, the focus is on the resulting change in the ownership structure of a major holder, rather than a routine buyback (POS) or a general M&A bid (TAR).
2014-07-09 English
Medistim har mottatt klarering fra Russland for salg av VeriQ C
Regulatory Filings Classification · 100% confidence The document is a short announcement (2828 characters) in Norwegian stating that Medistim has received clearance from Russian health authorities to sell its VeriQ C product. It details the product, market potential in Russia, and mentions prior clearances (FDA, CE, Japan, Canada). The final sentence states, "Denne opplysningen er informasjonspliktig etter norsk lov (Verdipapirhandelloven § 5-12)" (This information is subject to disclosure under Norwegian law). This structure—a brief announcement of a material event that is legally required to be disclosed—fits best under the general Regulatory Filings category (RNS), as it is not a full financial report (10-K, IR), an earnings release (ER), a management discussion (MDA), or a specific transaction report (like DIRS or POS). It is a general regulatory disclosure.
2014-06-25 Norwegian
Medistim has received clearance from Russia for sale of VeriQ C
Regulatory Filings Classification · 100% confidence The document is a short announcement from Medistim dated June 25th, 2014, stating that they have received clearance from Russian health authorities to sell their product VeriQ C. It details the product, market potential in Russia, and mentions previous clearances (FDA, CE, Japan, Canada). This is a specific operational update regarding market access and regulatory approval, not a comprehensive financial report (like 10-K or IR), a management change (MANG), or a dividend announcement (DIV). Since it is a specific regulatory/operational update that doesn't fit the primary financial filing codes, and it is not an announcement *about* a report (RPA), the most appropriate general category for miscellaneous regulatory/operational news that doesn't fit elsewhere is Regulatory Filings (RNS).
2014-06-25 English
Resultat for 1. kvartal 2014 for Medistim ASA
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive quarterly financial report for Medistim ASA for the first quarter of 2014. It contains detailed financial statements (income statement, balance sheet, key performance indicators), management discussion and analysis of operational status, market trends, and outlook. It is not an announcement of a report, but the report itself, and it provides substantive financial data, fitting the definition of an Interim/Quarterly Report (IR). Q1 2014
2014-04-25 Norwegian
First quarter results 2014 for Medistim ASA
Interim / Quarterly Report Classification · 100% confidence The document is titled '1. quarter report and financials for 2014'. It contains comprehensive financial statements (Profit & Loss, Balance Sheet data), management commentary on operational status, market trends, and financial performance for the first quarter of 2014. It is not an announcement of a report, but the report itself, containing substantive financial data and analysis, fitting the definition of an Interim/Quarterly Report. Q1 2014
2014-04-25 English
Resultat for 1. kvartal 2014 for Medistim ASA
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive financial report for Medistim ASA for the first quarter of 2014. It contains detailed financial statements (Profit and Loss, Balance Sheet), business segment updates, and management analysis of performance. It is not an announcement (RPA) or a transcript (CT), but rather the actual interim financial report for the period, fitting the definition of an Interim/Quarterly Report (IR). Q1 2014
2014-04-25 Norwegian

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.